Infectious Diseases Society Of America Guideline Update
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 85:00:41
- Mais informações
Informações:
Sinopse
The Infectious Diseases Society of America's Guideline Update presents concise summaries of IDSA guidelines. For details of the guidelines, please go to www.idsociety.org .Host: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital.
Episódios
-
Is life better in locum? A locum tenens ID physician shares her story
01/07/2023 Duração: 24min“Everything's negotiable in the locums world.” Locum tenens is a career path that is often discouraged for ID professionals. In this Let’s Talk ID episode with host Paul Sax, MD, FIDSA, locum tenens ID physician Allison Nazinitsky, MD shares how life in locum tenens provides better pay, work-life balance and a sense of appreciation.
-
Is the grass greener? Life as an ID physician working in private practice
10/06/2023 Duração: 31min“We need to start dispelling the myth that you're not able to make money doing [what you love].” After matching into physical medicine and rehabilitation and spending a gap year as a hospitalist, Alice Han, MD decided to pursue a career in infectious diseases. In this episode with Dr. Paul Sax, Dr. Han shares the reason she switched specialties, what it’s like working in ID private practice and the key to having professional satisfaction in ID.
-
It takes two to make a thing go right: maximizing the mentor/mentee relationship
27/05/2023 Duração: 25minTwenty years ago, Buddy Creech, MD, MPH, FPIDS became a pediatric infectious diseases fellow under mega-mentor Kathryn Edwards, MD, FIDSA, FPIDS. In this episode, Dr. Creech is joined by his former mentor to discuss their story, the dynamics of a successful mentee and mentor relationship, and how to mentor trainees in the best way possible.
-
Advocacy, Equity and Beyond: The End of the COVID-19 Emergency Order
11/05/2023 Duração: 29minThe lifting of the COVID-19 public health emergency (PHE) at the federal level will have significant impact on clinical, public health and research in infectious diseases beyond. In this episode, director of health for the city of St. Louis Mati Hlatshwayo Davis, MD, MPH is joined by Allison Agwu, MD, ScM, FIDSA and Maximo Brito, MD, MPH, FIDSA to discuss the urgency for prioritizing health equity beyond the COVID-19 Emergency Order Conclusion.
-
President's Podcast: Lifting the COVID-19 Public Health Emergency
02/05/2023 Duração: 20minIDSA President Carlos del Rio MD, FIDSA, discusses the end of the COVID-19 public health emergency (PHE) with White House COVID-19 Response Coordinator Ashish Jha, MD, MPH.
-
Communicating science and addressing misinformation
22/04/2023 Duração: 38minBuddy Creech, MD, MPH, FPIDS, sits down with guests William Schaffner, MD, FIDSA, and NBC News medical correspondent Erika Edwards to discuss how ID practitioners can be better communicators.
-
A travel history to beat all travel histories
08/04/2023 Duração: 24minThe next time you take a careful travel history, think what it would be like to ask comedy writer Mike Reiss — he and his wife have been to more than a hundred countries, many of them far from the usual tourist routes. Paul Sax, MD, FIDSA, sits down with Reiss to discuss the good, the bad and the ugly.
-
Joining IDSA’s Board of Directors: Is it really only for senior career professionals?
28/03/2023 Duração: 24min“If you have something to contribute, that contribution is going to be valued.” In 2019, Jasmine Marcelin, MD, FIDSA, became the youngest person to be elected to the IDSA Board of Directors. In this episode, Dr. Marcelin shares her journey, from experiencing “imposter syndrome,” balancing board work with a career and young children, and why age shouldn’t deter you from applying.
-
Three effective treatments for COVID-19 not (yet) in guidelines
25/03/2023 Duração: 25minPaul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines.*This episode was recorded before the Paxlovid EPIC-SR results were released in an FDA briefing.
-
Joining IDSA’s Board of Directors: A Clinician’s Perspective
21/03/2023 Duração: 18minIDSA President-Elect Steven K. Schmitt, MD, FIDSA and IDSA Immediate Past President Daniel P. McQuillen, MD, FIDSA discuss their experience as clinicians serving on the IDSA Board of Directors.
-
President's Podcast: ID/EIS Joint Fellowship
11/03/2023 Duração: 26minThe ID/EIS joint fellowship streamlines a career path for applicants interested in both the ID fellowship and EIS program. In this episode, IDSA President Carlos del Rio, MD, FIDSA speaks with Molly Paras, MD, Program Director of Massachusetts General Hospital/Brigham and Women’s Hospital Infectious Diseases Fellowship and Eric Pevzner, MD Chief of the Epidemiology and Laboratory Workforce Branch in the Division of Workforce Development at CDC about the new opportunity and the value it will bring to public health. To learn more, visit idsociety.org/ideisfellowship.
-
President’s Podcast: Bio-Preparedness Workforce Pilot Program
28/02/2023 Duração: 14minThe Bio-Preparedness Workforce Pilot Project was included in the BIO Preparedness Workforce Act that was passed by Congress at the end of 2022. In this episode, IDSA President Carlos del Rio, MD, FIDSA speaks with Paul Pottinger, MD, DTMH, FACP, FIDSA of the University of Washington and Emily Spivak, MD, MHS, FIDSA of the University of Utah about the program and how it will address ID workforce needs. Learn more about the Bio-Preparedness Workforce Pilot Project.
-
Top Associations in Clinical ID
25/02/2023 Duração: 30minMowing a lawn in Martha's Vineyard and getting tularemia. Swimming in Lake Malawi and getting schistosomiasis. In a game that mirrors a fantasy sports draft, Paul Sax, MD, FIDSA and Rebeca Plank, MD, MPH take turns picking favorite ID associations.
-
President's Podcast: Medical Education and Recruitment Challenges
14/01/2023 Duração: 22minIDSA President Carlos del Rio, MD, FIDSA, Wendy Armstrong, MD, FIDSA, FACP and Erin Bonura, MD, discuss medical education including the latest Match results, recruitment challenges and the work of IDSA’s Med Ed Community of Practice.
-
President's Podcast: A Conversation with Dr. Anthony Fauci: Strengthening the Future of ID
10/12/2022 Duração: 18minIDSA President Carlos del Rio, MD, FIDSA, is joined by Anthony Fauci, MD, FIDSA, who will step down as NIAID director this month after 38 years, to discuss Dr. Fauci’s role as director, pandemic preparedness and what ID professionals can do to help recruit more medical students into the field.
-
President's Podcast: IDWeek 2022 Recap
22/11/2022 Duração: 17minIDSA President Carlos del Rio, MD, FIDSA recaps IDWeek 2022 with IDWeek Program Committee Chair Adarsh Bhimraj, MD, FIDSA and Vice-Chair Heather Yun, MD.
-
Honoring Native American Heritage Month
19/11/2022 Duração: 15minMati Hlatshwayo Davis, MD, MPH and Jessica Snowden, MD, FIDSA share actions that providers and health systems can take to ensure equitable care for Native American and Alaska Native communities.
-
An Update on Long COVID (Oct. 29, 2022)
29/10/2022 Duração: 24minIgho Ofotokun, MD, FIDSA, principal investigator of the RECOVER study funded by NIH, and Alba Azola, MD, co-director of the Johns Hopkins Post-Acute COVID-19 Team, discuss the latest research on long COVID.
-
Reaching Underserved Communities: Lessons from Grady in Atlanta
15/10/2022 Duração: 17minInfectious disease physicians Dr. Valeria Cantos and Dr. Paulina Rebolledo of Emory University School of Medicine discuss their work with the Latino Community Fund to bolster community awareness on COVID-19 boosters and antivirals.
-
COVID-19 Bivalent Vaccine Boosters (Sept. 24, 2022)
24/09/2022 Duração: 13minKathryn Edwards, MD, FIDSA and Keipp Talbot, MD, FIDSA of Vanderbilt University School of Medicine discuss COVID-19 bivalent vaccine boosters, including how bivalent vaccines are used, the differences between the Moderna and Pfizer boosters and if boosters will become an annual occurrence.